These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18234506)

  • 21. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Washington statewide pathology surveillance for prion disease.
    Allen CT; Sonnen J; Leslie MJ; Kidoguchi L; Harris C; Gambetti P; Montine TJ
    Ann Neurol; 2007 Apr; 61(4):371-2. PubMed ID: 17358023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low copper and high manganese levels in prion protein plaques.
    Johnson CJ; Gilbert PU; Abrecht M; Baldwin KL; Russell RE; Pedersen JA; Aiken JM; McKenzie D
    Viruses; 2013 Feb; 5(2):654-62. PubMed ID: 23435237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion disease causes less severe lesions in human hippocampus than other parts of brain.
    Kaneko M; Sugiyama N; Sasayama D; Yamaoka K; Miyakawa T; Arima K; Tsuchiya K; Hasegawa K; Washizuka S; Hanihara T; Amano N; Yagishita S
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):264-70. PubMed ID: 18588585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kuru: its ramifications after fifty years.
    Liberski PP; Brown P
    Exp Gerontol; 2009; 44(1-2):63-9. PubMed ID: 18606515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creutzfeldt-Jakob disease: a disease overview.
    Cyngiser TA
    Am J Electroneurodiagnostic Technol; 2008 Sep; 48(3):199-208. PubMed ID: 18998478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.
    Shi Q; Gao C; Zhou W; Zhang BY; Chen JM; Tian C; Jiang HY; Han J; Xiang NJ; Wang XF; Gao YJ; Dong XP
    BMC Public Health; 2008 Oct; 8():360. PubMed ID: 18928564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease.
    Brazier MW; Doctrow SR; Masters CL; Collins SJ
    Free Radic Biol Med; 2008 Jul; 45(2):184-92. PubMed ID: 18455516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sleep disorders in prion diseases].
    Ayuso T; Tuñón T; Erro ME
    An Sist Sanit Navar; 2007; 30 Suppl 1():135-41. PubMed ID: 17486154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route.
    Sisó S; Jeffrey M; González L
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):232-46. PubMed ID: 19473292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper and prion diseases.
    Brown DR
    Biochem Soc Trans; 2002 Aug; 30(4):742-5. PubMed ID: 12196183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
    Zhang W; Wu J; Li Y; Carke RC; Wong T
    Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for sporadic Creutzfeldt-Jakob disease].
    Kittner C; Heinemann U; Zerr I
    Dtsch Med Wochenschr; 2009 Jul; 134(27):1429-35. PubMed ID: 19551608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases.
    Mannila A; Rautio J; Lehtonen M; Järvinen T; Savolainen J
    Eur J Pharm Sci; 2005 Jan; 24(1):101-5. PubMed ID: 15626583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prions and prion diseases.
    Beekes M
    FEBS J; 2007 Feb; 274(3):575. PubMed ID: 17288546
    [No Abstract]   [Full Text] [Related]  

  • 38. Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study.
    Gelpi E; Heinzl H; Hoftberger R; Unterberger U; Strobel T; Voigtlander T; Drobna E; Jarius C; Lang S; Waldhor T; Bernheimer H; Budka H
    Neuroepidemiology; 2008; 30(4):215-21. PubMed ID: 18424902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cytokines and chemokines in prion infections of the central nervous system.
    Burwinkel M; Riemer C; Schwarz A; Schultz J; Neidhold S; Bamme T; Baier M
    Int J Dev Neurosci; 2004 Nov; 22(7):497-505. PubMed ID: 15465279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.